Observations placeholder

Ezetimibe/simvastatin  is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (known as Zetia in the United States and Ezetrol elsewhere) and the statin drug simvastatin (known as Zocor in the U.S.). The combination preparation is marketed  under the trade names Vytorin in the US and Inegy in Europe.

Ezetimibe reduces blood cholesterol by acting at the brush border of the small intestine and inhibiting the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.

Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.

Most common Vytorin side effects from eHealthme

• Nausea - (1,223 reports)
• Weakness - (1,110 reports)
• Pain - (1,007 reports)
• Fatigue - (985 reports)
• Dizziness - (927 reports)
• Breathing difficulty - (883 reports)
• Drug ineffective - (869 reports)
• Stress and anxiety - (801 reports)
• Muscle aches - (756 reports)
• High blood pressure - (734 reports)

On Jan, 14, 2017  16,123 people reported to have side effects when taking Vytorin.
Among them, 281 people (1.74%) have Death

On Feb, 14, 2017  16,123 people reported to have side effects when taking Vytorin.  Among them, 66 people (0.41%) have Hallucination

On Feb, 14, 2017  16,123 people reported to have side effects when taking Vytorin.  Among them, 23 people (0.14%) have Hallucination, Auditory